Advanced Technology International selected to manage new BARDA Biopharmaceutical Manufacturing Preparedness Consortium

2024-01-04
SUMMERVILLE, S.C., Jan. 4, 2024 /PRNewswire/ -- Advanced Technology International (ATI) has been awarded an Other Transaction (OT) Agreement by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness (ASPR) and Response within the U.S. Department of Health and Human Services, to serve as the consortium manager for the new 10-year Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium). The BioMaP-Consortium aims to improve and expand the industrial and manufacturing base for medical countermeasures during and in between public health emergencies. The BioMaP-Consortium is comprised of industry partners across the drug and vaccine manufacturing supply chain, including manufacturers of required raw materials and consumables, suppliers of drug substance manufacturing and fill finish services, and developers of innovative manufacturing technologies.
"ATI recognizes the public health threats our nation faces, and we are committed to BARDA's pursuit to fortify the nation's health security and bolster preparedness and response capabilities," said Chris Van Metre, ATI President and CEO. "We are honored to be selected to support BARDA in accelerating the development and delivery of these lifesaving medical countermeasures."
For more information about the BioMaP-Consortium or to learn how to join, please visit biomap-consortium.org.
This project has been funded in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under OT number #75A50123D00003.
ABOUT ATI:
ATI, a public-service nonprofit based in Summerville, S.C., builds and manages collaborations that conduct research and development of new capabilities to solve our nation's most challenging problems. Supported by a community of experts from industry, academia, and government, ATI expedites innovation to help the federal government quickly identify and acquire novel technologies and solutions.
ATI.org | LinkedIn | X | collaborATIon app
SOURCE ATI (Advanced Technology International)
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。